Here are the 424B prospectus supplements from Antiaging Qntum LGN A (AAQL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow AAQL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AAQL filings page.
Antiaging Quantum Living Inc. is registering up to 4,280,340 shares of Class A Common Stock for resale by existing stockholders, representing shares issued upon automatic conversion of amended promissory notes at a fixed price of $0.30 per share. The company will not receive any proceeds from the sale of these shares, which may be sold from time to time in public or private transactions. Antiaging Quantum Living operates a small U.S. online advertising platform focused on New York professionals and has expanded into higher-growth PRC technical-service and non-medical health-management businesses under the “Dao Ling Doctor” brand, while facing significant risks related to limited operating history, need for additional capital, reliance on a single key executive, competition, thin OTC Pink trading, and potential dilution from future equity financing.